Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NXF
|
|||
| Former ID |
DNCL001815
|
|||
| Drug Name |
Mydicar
|
|||
| Synonyms |
Mydicar (TN)
Click to Show/Hide
|
|||
| Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 2 | [1] | |
| Company |
Celladon; Targeted Genetics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00534703) Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure and a Left Ventricular Assist Device. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Celladon. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.